Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1652-1658

  Barnes, Neil ^a   Laviolette, Michel ^b   Allen, David ^c   Flood Page, Patrick ^d   Hargreave, Frederick ^e   Corris, Paul ^f   J O'Connor, Brian ^g   Tate, Helen ^h   Parker, Debbie ⁱ   Pavord, Ian ⁱ  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b LAVAL UNIVERSITY   (Canada)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^d Newport Chest Clin   (United Kingdom)

^e MCMASTER UNIVERSITY   (Canada)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h Merck Sharp & Dohme Limited   (United Kingdom)

ⁱ GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Asthma; Clinical trial; Eosinophils; Mediators; Sputum

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; INTERLEUKIN 8; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MONTELUKAST; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG RESPONSE; EOSINOPHIL; FEMALE; HUMAN; INHALER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPHIL; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACETATES; ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; QUINOLINES; SPUTUM; TREATMENT OUTCOME;

EID: 34250620822     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.03.007     Document Type: Article

References (24)

1. Jeffrey P.K., Laitinen A., and Venge P. Biopsy markers of airway inflammation and remodelling. Respir Med 94 Suppl. F (2000) S9-S15
2. Fahy J.V., Boushey H.A., Lazarus S.C., et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicentre study. Am J Respir Crit Care Med 163 (2001) 1470-1475
3. In't Veen J.C.C.M., De Gouw H.W.F.M., Smits H.H., et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 9 (1996) 2441-2447
4. Pizzichini E., Pizzichini M.M.M., Efthimidias A., et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 154 (1996) 308-317
5. Pavord I.D., Pizzichini M.M., Pizzichini E., and Hargreave F.E. The use of induced sputum to investigate airway inflammation. Thorax 52 (1997) 498-501
6. Pavord I.D., Brightling C.E., Woltmann G., and Wardlaw A.J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 353 (1999) 2213-2214
7. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58 (Suppl. 1): 1-94.
8. Pizzichini M.M.M., Kidney J.C., Wong B.J.O., et al. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Eur Respir J (1996) 449-455
9. Sampson A.P., Pizzichini E., and Bisgaard H. Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation. J Allergy Clin Immunol 111 (2003) S49-S59
10. Laviolette M., Malmstrom K., Lu S., et al. Montelukast added to inhaled becolmethasone in treatment of asthma. Am J Respir Crit Care Med 160 (1999) 1862-1868
11. Virchow J.C., Prasse A., Naya I., Summerton L., and Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 162 2 Pt 1 (2000) 578-585
12. Price D.B., Hernandez Magyar D.P., Fiterman J., et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 58 (2003) 211-216
13. Santanello N.C., Barber B.L., Reiss T.F., Friedman B.S., Juniper E.F., and Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 10 (1997) 646-651
14. Juniper E.F., Guyatt G.H., Epstein R.S., Ferrie P.J., Jaeschke R., and Hiller T.K. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials. Thorax 47 2 (1992) 76-83
15. Brightling C.E., Ward R., Woltmann G., et al. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 162 (2000) 878-882
16. Hodges Jr. J.L., and Lehmann E.L. Estimates of location based on rank tests. Ann Math Stat 27 (1963) 598-611
17. Jayaram L., Duong M., Pizzichini M.M.M., et al. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma. Eur Respir J 25 (2005) 41-46
18. Green R.H., Brightling C.E., McKenna S., et al. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and airway responsiveness. Eur Respir J 27 (2006) 1144-1151
19. Pizzichini E., Leff J.A., Reiss T.F., et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 14 (1999) 12-18
20. Jayaram L., Pizzichini E., Lemière C., et al. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Thorax 60 (2005) 100-105
21. Green R.H., Brightling C.E., McKenna S., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
22. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., and Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167 2 (2003) 199-204
23. Brown R.H., Zerhouni E.A., and Mitzner W. Airway edema potentiates airway reactivity. J Appl Physiol 79 (1995) 1242-1248
24. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., and Pavord I.D. Mast cell infiltration of airway smooth muscle in asthma. N Engl J Med 346 (2002) 1699-1705